The bocx obviously does not want to discuss why Abbott has not declared RECAF feasible per the feasibiliy study.
As the bocx stated, it is obviously feasible to actually perform the test as shown in the ISOBM results so why isn't it feasible.
Moro actually answered that question in the March answers to shareholder questions.
" This is not necessarily the case for our licensees (particularly their Management because scientists working on the bench soon become staunch supporters of the technology as THEY make it work in their labs). The “deciders” are far removed from the excitement of the results and see this just as another source of revenue."
I think Moro inadvertantly summed it up quite nicely. It if doesn't meet management revenue parameters, it certainly would not be feasible. So why did Abbott negotiate an amendment to put RECAF essentially on "hold". Moro actually gave a good hint as to that reason also. "scientists working on the bench soon become staunch supporters of the technology as THEY make it work in their labs). It appears that Frost and Dowell went to bat for Moro and after Moro kicking in the $50,000 management would save in not paying the 2008 minimum royalty, an amendment was struck. If someone else does the PMA, it could change the revenue return aspect.
Now, it is obvious that this amendment was not good news for Inverness. Inverness would now be the lead developer of RECAF and sustain all the costs of a PMA in addition to having to develop 100% of the market. Inverness now went from a low risk of a tag along with a 510(k) to a high risk go it alone posture.
It was obvious that Inverness and Moro were having discussions about this because he immediately contacted Inverness when AMDL got FDA approval of DR-70 to monitor colon cancer. Did that interest Inverness? Don't know but we surely have not seen any form or development on their part.
On June 6th, Moro announced the ELISA format. A few days later, he immediately announced the intent to commercialize the test with licensees. He would get up front money, minimum sales, etc, etc. He stated that he was discussing terms with labs. Well, no labs signed on so what does Moro do now? I think that is how Moro arrived at the decision attempt to market in China. I do not think he has much of a choice now. It is apparently China or nothing.
